ArticleFrontiers in public health2025
Analysis of the global burden of neonatal disorders and risk factors from 1990 to 2021: findings from the global burden of disease study 2021.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Long-term disability after neonatal encephalopathy in low-resource settings.Pediatric research · 2026Article
- Persistent inequities in neonatal encephalopathy: a 30-year global burden analysis (1990-2021).Frontiers in pediatrics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Neonatal health represents a critical global issue, encapsulating both the advancements and challenges faced by health systems at both global and national levels. Neonatal disorders not only impose a significant disease burden, diminishing the quality of life for affected individuals, but they also contribute to substantial economic strain. Methods: This article utilizes the Global Burden of Disease 2021 database to describe the global burden of neonatal disorders in 2021 through age-standardized incidence rate, age-standardized prevalence rate, age-standardized death rate, and age-standardized disability-adjusted life years rate. Additionally, it employs the estimated annual percentage change to delineate the trends in the global burden of neonatal disorders from 1990 to 2021. Results: The global age-standardized incidence rate, age-standardized prevalence rate, age-standardized death rate, and age-standardized disability-adjusted life years rate for neonatal disorders were 437.43 (95% UI = 433.20 to 441.95) per 100,000 population, 437.43 (433.20 to 441.95), 29.57 (25.37 to 34.26), and 2941.98 (2547.76 to 3384.20), respectively. Conclusion: From 1990 to 2021, the global burden of neonatal disorders exhibited a general downward trend, with a particularly pronounced burden in South Asia and Southern Sub-Saharan Africa. Countries characterized by low socio-demographic index and low-middle socio-demographic index faced a disproportionately higher burden of neonatal disorders. Low birth weight emerged as a significant contributor to both the age-standardized death rate and the age-standardized disability-adjusted life years rate associated with global neonatal disorders. Therefore, health departments across various nations should prioritize the enhancement of healthcare systems and the quality of care to alleviate the burden of neonatal disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.